Daiichi Sankyo Co Ltd ADR (DSNKY)
Daiichi Sankyo Co Ltd ADR is a depositary receipt listed on OTC Markets that represents common stock of Daiichi Sankyo Company, Limited, a pharmaceutical company with operations in Japan, the United States, Europe, and other international markets. The underlying business develops, manufactures, and sells a broad range of prescription medicines spanning oncology, cardiovascular, diabetes, migraine, bone health, pain management, anemia, and infectious disease. Its portfolio includes products such as Enhertu, Turalio, Vanflyta, Injectafer, DATROWAY, Savaysa, Minnebro, Olmetec, Nilemdo, Nustendi, and Vimpat, among others. The company also markets vaccines for COVID-19, influenza, measles/rubella, mumps, and related infections. In addition, Daiichi Sankyo has a strategic collaboration with Lunit Inc. focused on biomarker discovery and translational research.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-DSNK.Y
|
$25.33
|
33.3% Upside
|
Undervalued
|
$22.95
|
20.8% Upside
|
Undervalued
|
Great
|
0.0%
|
October 30, 2026
|
20.5x
|
3.2x
|
2.4x
|
34.154 B
|
32.224 B
|
8.5%
|
8.2
|
-0.9%
|
